Abraxis BioScience Cash Flow Statement
View: Annual | Quarterly
| Dec 08 | Dec 07* | Dec 98 | |
|---|---|---|---|
| Net Operating Cash Flow | (315.5) | (2.9) | -- |
| Net Investing Cash Flow | (85.6) | (44.9) | -- |
| Net Financing Cash Flow | 2.4 | 752.1 | -- |
| Net Change in Cash | (398.7) | 704.6 | -- |
| Depreciation & Amortization | 39.4 | 49.1 | -- |
| Capital Expenditures | (43.7) | (44.9) | -- |
| Cash Dividends Paid | -- | -- | -- |
© 2009 Morningstar, Inc. Financial Data provided by
